Hemimegalencephaly: diagnosis and treatment

J Q Trounce1, N Rutter, D H Mellor

  • 1Department of Child Health, University Hospital, Nottingham.

Insights

Hemimegalencephaly is a rare brain malformation causing seizures and developmental delay in children. Early recognition via imaging and potential response to benzodiazepines offer treatment avenues.

Area of Science:

  • Neurology
  • Developmental Neuroscience
  • Pediatric Neurology

Background:

  • Hemimegalencephaly is a congenital brain malformation characterized by unilateral or generalized enlargement of one cerebral hemisphere.
  • This condition often presents with severe neurological symptoms, including intractable epilepsy and developmental deficits.

Observation:

  • Report details three male patients diagnosed with hemimegalencephaly.
  • Clinical presentations included neonatal convulsions and later-onset seizures, with abnormal electroencephalogram (EEG) findings showing spike and wave activity.
  • Associated features observed were macrocephaly, hemiparesis, facial hemihypertrophy, and linear nevus.

Findings:

  • Hemimegalencephaly diagnosis is supported by cranial ultrasonography findings.
  • Patients exhibited significant developmental delay alongside epilepsy and other neurological manifestations.
  • Seizure activity in these cases showed potential responsiveness to benzodiazepine therapy.

Implications:

  • Highlights the importance of early neuroimaging for diagnosing hemimegalencephaly.
  • Suggests benzodiazepines as a potential therapeutic option for managing seizures associated with this condition.
  • Emphasizes the complex neurodevelopmental challenges faced by affected individuals, necessitating comprehensive care strategies.